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Conclusions: The clinical outcome of RSV infec- 
tions in lung transplant patients seems to be de- 
pendent on the degree of immunosuppression. Re- 
duction of immunosuppression might be sufficient 
in selected cases and aggressive anti-RSV therapies 
could be restricted to patients under intense im- 
munosuppression. 
41 
Three Cases of Septic Gas Gangrene Post-Liver 
Transplantation Successfully Treated with 
Retransplantation 
S. Dob[ecki Lewis*, A.G. Tzakis, M.I. Morris. 
University o[ Miami~Jackson Memorial Hospital, 
Miami, FL, USA 
Background: Gas gangrene is a rare and devastat- 
ing infectious process that most often occurs fob 
[owing penetrating trauma or post-operatively. Gas 
gangrene of a transplanted liver has been reported 
rarely. We report three cases of gas gangrene fob 
[owing orthotopic liver transplantation. Blood cub 
tures were positive for Clostridium clostrdiil:orme 
in one case. In two other cases liver tissue from ex- 
planted specimens were positive for Enterobacter 
cloacae. Ultrasound demonstrated hepatic artery 
thrombosis and computed tomography imaging re- 
vea[ed diffuse necrosis with gas formation in each 
case. A[[ three patients were successfully treated 
with a combination of antibiotics and emergent re- 
transplantation. This is the largest series of post- 
transplant occurrences of septic gas gangrene. In 
the adult literature, a total of eight cases with 
two successful re-transplants have been previously 
reported. Hepatic artery thrombosis was a com- 
mon preceding event to these infections. Early 
diagnosis and aggressive combined medical and 
surgical treatment including re-transplantation are 
essential to successful treatment of these rare and 
usua[[y fata[ infections. 
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Background & Objectives: The rate of IC due to 
non-a[bicans Candida (NAC) and associated azo[e- 
resistance has been rising. IC is a serious complica- 
tion of SOT and this study assesses the epidemio[- 
ogy of IC in our SOT population, fluconazo[e (FLU) 
resistance and outcomes. 
Methods: A retrospective review was performed 
of abdominal SOT recipients with IC between 
2001 and 2004. Cases were identified by cross- 
matchin g microbiology lab data of non-urinary, 
non-respiratory Candida isolates with our SOT 
database. Demographic, clinical and lab data were 
recorded; IRB approval was obtained. 
Results: 539 SOT were performed: 337 re- 
nal transplants (RT), 167 liver transplants (LT), 
17 kidney-pancreas transplants (KPT), 9 each 
small bowel (SBT) and pancreas transplants (PT). 
16 (3.0%) pts developed 17 episodes of IC within 
6 months (mo) of SOT (Table 1). The highest rates 
of IC were among LT and SBT. 9/17 episodes of 
IC (53%) were intraabdomina[ (IA), 5 (29%) were 
bloodstream (BS), 2 (12%)were both IA+BS, and 
1 (6%) was an abdominal wail abscess. 13/17 (77%) 
episodes completely responded (CR) to antifun- 
ga[ (AF) therapy and 4/17 (24%) were failures 
(4/4 patients expired). 
Tabte 1. IC within 6 mo of SOT. 
Organ 2001 2002 2003 2004 Overa[[ 
RT 0•65 3a170 0•94 I1108 4a1337 
(4.3%) (0.9%) (I .2%) 
LT 2•24 2a141 4151 4151 12a1167 
(8.3%) (4.9%) (7.8%) (7.8%) (7.2%) 
PT NA 014 012 013 019 
KPT 015 012 015 015 0117 
SBT NA 111 013 015 119 
(100%) (11.1%) 
Total 2/94 5/118 4/155 5/172 16/539 
(2.1%) (4.2%) (2.6%) (2.9%) (3.0%) 
Mean time 34 45 72.8 15.8 15.8 
to IC from (7-61) (5-125) (16-173) (3-33) (3-33) 
SOT (d) 
al combined LT/RT, counted twice. 
13 additional pts had late-onset (>6 mo post-SOT) 
IC during the study period: 6/13 (46%) RT, 3 (23%) 
combined LT/RT, 2 (15%) LT, and 1 each (8%) SBT 
and KPT. Sites included 10 (77%) BS and 3 (23%) 
IA and the mean time to IC after SOT was 45 mo 
(range 7-115). 10/13 (77%) had CR and 1 each (8%) 
had: repeat cultures negative without AF therapy, 
death prior to AF therapy, and death on therapy 
despite CR prior to death. For a[[ 30 episodes, NAC 
and FLU resistance rates varied by year (Table 2). 
NAC rates were as follows: 23% C. glabrata, 16% 
C. parapsilosis, 13% C. tropicalis, and 6% C. krusei. 
Tab[e 2. Incidence of NAC and FLU resistance. 
Year 2001 2002 2003 2004 
NAC 315 (60%) 719 (78%) 619 (67%) 217 (29%) 
FLU resistance 112 (50%) 219 (22%) 017 016 
Conclusions: Most early IC were in LT pts and most 
[ate IC were in RT pts. The incidence of IC was 
stable with a high rate of NAC. Fortunately, FLU 
resistance was rare. 
